94 related articles for article (PubMed ID: 11715667)
21. Current status and future directions of chemosensitivity testing.
Sevin BU; Perras JP; Köchli OR
Contrib Gynecol Obstet; 1994; 19():179-94. PubMed ID: 7995049
[No Abstract] [Full Text] [Related]
22. [Actual state of ex vivo chemoresistance testing of malignant tumors in Masaryk Memorial Cancer Institute Brno].
Poprach A; Michalová E; Pavlík T; Lakomy R; Vyskocil J; Nemeccek R; Zaloudík J; Vyzula R; Kocák I; Kocáková I
Klin Onkol; 2008; 21(3):116-21. PubMed ID: 19097421
[TBL] [Abstract][Full Text] [Related]
23. Evaluating response to antineoplastic drug combinations in tissue culture models.
Reynolds CP; Maurer BJ
Methods Mol Med; 2005; 110():173-83. PubMed ID: 15901935
[TBL] [Abstract][Full Text] [Related]
24. Chemosensitivity testing using microplate adenosine triphosphate-based luminescence measurements.
Kurbacher CM; Cree IA
Methods Mol Med; 2005; 110():101-20. PubMed ID: 15901931
[TBL] [Abstract][Full Text] [Related]
25. A chemosensitivity test for superficial bladder cancer based on three-dimensional culture of tumour spheroids.
Burgués JP; Gómez L; Pontones JL; Vera CD; Jiménez-Cruz JF; Ozonas M
Eur Urol; 2007 Apr; 51(4):962-9; discussion 969-70. PubMed ID: 17084017
[TBL] [Abstract][Full Text] [Related]
26. [Chemosensitivity testing and the drug resistance of human tumors].
Ludwig C
Dtsch Med Wochenschr; 1989 Sep; 114(36):1375-9. PubMed ID: 2673717
[No Abstract] [Full Text] [Related]
27. [Establishment of a human nasopharyngeal carcinoma drug-resistant cell line CNE2/DDP and screening of drug-resistant genes].
Jiang RD; Zhang LX; Yue W; Zhu YF; Lu HJ; Liu X; Cen XT; Guan XY; Li CH
Ai Zheng; 2003 Apr; 22(4):337-45. PubMed ID: 12703984
[TBL] [Abstract][Full Text] [Related]
28. Prediction of anti-tumour effect of thermochemotherapy with in vitro thermochemosensitivity testing for non-small cell lung cancer.
Abiko T; Kawamura M; Izumi Y; Oyama T; Saito Y; Kobayashi K
Int J Hyperthermia; 2007 May; 23(3):267-75. PubMed ID: 17523019
[TBL] [Abstract][Full Text] [Related]
29. [Predictive value of in vitro MTT assay chemosensitivity test of cytotoxic drug activity in cervical cancer].
Xiao Y; Li JD; Shi HL; Liu JH; Feng YL; Li MD
Ai Zheng; 2007 Apr; 26(4):386-9. PubMed ID: 17430657
[TBL] [Abstract][Full Text] [Related]
30. [Establishing the method of collagen-gel droplet embedded culture drug sensitivity test with rat tail collagen].
Hu Y; Zhou T; Liao Q; Zhang TP; Chen G; Zhao YP
Zhonghua Wai Ke Za Zhi; 2008 Jul; 46(13):998-1001. PubMed ID: 19035202
[TBL] [Abstract][Full Text] [Related]
31. Overview of tumor cell chemoresistance mechanisms.
Gatti L; Zunino F
Methods Mol Med; 2005; 111():127-48. PubMed ID: 15911977
[TBL] [Abstract][Full Text] [Related]
32. Cell viability assay for drug testing in ovarian cancer: in vitro kill versus clinical response.
Ness RB; Wisniewski SR; Eng H; Christopherson W
Anticancer Res; 2002; 22(2B):1145-9. PubMed ID: 12168915
[TBL] [Abstract][Full Text] [Related]
33. A prospective randomized controlled trial of tumour chemosensitivity assay directed chemotherapy versus physician's choice in patients with recurrent platinum-resistant ovarian cancer.
Cree IA; Kurbacher CM; Lamont A; Hindley AC; Love S;
Anticancer Drugs; 2007 Oct; 18(9):1093-101. PubMed ID: 17704660
[TBL] [Abstract][Full Text] [Related]
34. [Cytotoxicity screening and mode of action of natural and synthetically prepared compounds usable in tumour chemotherapy].
Letasiová S; Jantová S; Milata V
Ceska Slov Farm; 2006 May; 55(3):99-109. PubMed ID: 16838486
[TBL] [Abstract][Full Text] [Related]
35. Molecular modes of action of cephalotaxine and homoharringtonine from the coniferous tree Cephalotaxus hainanensis in human tumor cell lines.
Efferth T; Sauerbrey A; Halatsch ME; Ross DD; Gebhart E
Naunyn Schmiedebergs Arch Pharmacol; 2003 Jan; 367(1):56-67. PubMed ID: 12616342
[TBL] [Abstract][Full Text] [Related]
36. Tumor chemosensitivity and chemoresistance assays.
Cree IA; Petty RD; Kurbacher CM; Untch M
Cancer; 1996 Nov; 78(9):2031-2. PubMed ID: 8909327
[No Abstract] [Full Text] [Related]
37. Clinical correlations for cell culture assays based on the concept of total tumor cell kill.
Weisenthal LM
Contrib Gynecol Obstet; 1994; 19():82-90. PubMed ID: 7995056
[No Abstract] [Full Text] [Related]
38. Evaluation of cell proliferation and cell death based assays in chemosensitivity testing.
Gerçel-Taylor C; Ackermann MA; Taylor DD
Anticancer Res; 2001; 21(4A):2761-8. PubMed ID: 11724352
[TBL] [Abstract][Full Text] [Related]
39. In vitro drug response assays for entry into the rational era cancer chemotherapy.
Hoffman RM
Hum Cell; 1995 Dec; 8(4):131-48. PubMed ID: 8721082
[No Abstract] [Full Text] [Related]
40. Chemosensitivity and chemoresistance testing.
Markman M
J Clin Oncol; 2005 Oct; 23(29):7363-4. PubMed ID: 16210675
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
